Lakewood-Amedex Biotherapeutics Inc. files a 8-K with the SEC
Filed: 2026-11-10 AccNo: 0001213900-26-118127 Size: 235 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-11-10 AccNo: 0001213900-26-118127 Size: 235 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read at SEC EDGARThe source’s licence allows a summary here, not the full story.Not investment advice. This article is for information only. Prices are as of publication; trader data is aggregated, anonymised and delayed 15 minutes.